Evidence map›Paper›PMID 40121324›Full record

ArticleJournal of human hypertension2025

Population-based surveillance for hypertension awareness, treatment, and control in nine districts - India Hypertension Control Initiative, 2018-19.

Prabhdeep Kaur, Kamaraj Pattabi, Amirthammal Gunasekaran, Vettrichelvan Venkatasamy, Azhagendran Sivalingam, Sabarinathan Ramasamy, Sailaja Bitragunta, Tapas Chakma, Sampada D Bangar, Meenakshi Sharma and 20 more

Abstract read
In one paragraph

Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Hypertension Prevalence, Risk Factors, and Care Cascade Among Nursing Staff at The Largest Tertiary-Care Hospital, Western Gujarat: A Cross-Sectional Study.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Prabhdeep Kaur *ICMR-National Institute of Epidemiology, Chennai, India. kprabhdeep@gmail.com.ORCID http://orcid.org/0000-0002-2605-3739
Kamaraj Pattabi *ICMR-National Institute of Epidemiology, Chennai, India.
Amirthammal GunasekaranICMR-National Institute of Epidemiology, Chennai, India.ORCID http://orcid.org/0000-0002-5043-2149
Vettrichelvan VenkatasamyICMR-National Institute of Epidemiology, Chennai, India.
Azhagendran SivalingamICMR-National Institute of Epidemiology, Chennai, India.
Sabarinathan RamasamyICMR-National Institute of Epidemiology, Chennai, India.
Sailaja BitraguntaICMR-National Institute of Epidemiology, Chennai, India.
Tapas ChakmaICMR-National Institute of Research in Tribal Health, Jabalpur, India.ORCID http://orcid.org/0000-0001-8304-8816
Sampada D BangarICMR-National AIDS Research Institute, Pune, India.
Meenakshi SharmaIndian Council of Medical Research, New Delhi, India.
Abhishek KunwarDept of Noncommunicable Diseases, WHO Country Office for India, New Delhi, India.
Kiran DurgadDept of Noncommunicable Diseases, WHO Country Office for India, New Delhi, India.
Anupam K PathniResolve to Save Lives, New Delhi, India.ORCID http://orcid.org/0000-0001-7582-0861
Sandeep S GillState NCD Cell, Department of Health and Family Welfare, Government of Punjab, Chandigarh, India.
Padmaja JogewarState NCD Cell, Directorate of Health Services, Government of Maharashtra, Mumbai, India.
Madhavi MallelaState NCD Cell, Department of Health, Medical and Family Welfare, Government of Telangana, Hyderabad, India.
Ashish SaxsenaState NCD Cell, Directorate of Health Services, Government of Madhya Pradesh, Bhopal, India.
Bipin GopalState NCD Cell, Directorate of Health Services, Government of Kerala, Thiruvananthapuram, India.
Bidisha DasIHCI Project, District NCD Cell, WHO-India, Bhatinda, Punjab, India.
Vishwajit BharadwajIHCI Project, District NCD Cell, WHO-India, Wardha, Maharashtra, India.
Pooja GaigawareICMR-National AIDS Research Institute, Pune, India.
Sreedhar ChintalaIHCI Project, District NCD Cell, WHO-India, Karimnagar, Telangana, India.
Chakshu JoshiIHCI Project, District NCD Cell, WHO-India, Ratlam, Madhya Pradesh, India.
Rupali BharadwajIHCI Project, District NCD Cell, WHO-India, Chhindwara, Madhya Pradesh, India.
Suyesh ShrivastavaICMR-National Institute of Research in Tribal Health, Jabalpur, India.
Pankaj UikeICMR-National Institute of Research in Tribal Health, Jabalpur, India.
Yannick P PuthusseryIHCI Project, District NCD Cell, WHO-India, Thrissur, Kerala, India.
Gopinath T SambandamIHCI Project, District NCD Cell, WHO-India, Kannur, Kerala, India.
R S DhaliwalIndian Council of Medical Research, New Delhi, India.
Balram BhargavaIndian Council of Medical Research, New Delhi, India.ORCID http://orcid.org/0000-0002-1707-1361

Funding

World Health Organization 001
6 · The paper itself

Abstract

Hypertension control is the crucial indicator for cardiovascular disease programs. We conducted a baseline cross-sectional survey to estimate hypertension awareness, treatment, and control in the selected districts in 2018-19, where the India Hypertension Control Initiative is being implemented. We conducted cross-sectional surveys in nine project districts for 18-69 years age group. The sample size was 624 per district. The study population was individuals with raised BP/diagnosed HT. We estimated the proportion and 95% confidence intervals (CI) for each district's awareness, treatment, and control. We computed unadjusted and adjusted prevalence ratios (APR) with 95% CI for factors associated with BP control. Hypertension was defined as systolic blood pressure (SBP) > = 140 or diastolic blood pressure (DBP) > = 90 mmHg or treatment in the previous two weeks. Control was defined as SBP < 140 and DBP < 90 mmHg. Among 7047 who had hypertension, 52.4% were aware, 40.8% were on treatment, and 14.5% had BP control. BP control was below 5% in two districts, 5-15% in three districts, and more than 15% in four districts. Among hypertensives aware of the diagnosis, the factors (APR with 95% CI) associated with control were lack of alcohol consumption [1.28 (1.09-1.52)], recent visit to government [1.98 (1.57-2.50)] or private facility [1.99 (1.61-2.46)] and treatment with single drug [2.40 (1.98-2.90)] or multiple drugs [2.84 (2.27-3.55)]. The simple, rapid population-based surveys can document awareness, treatment, and control changes. Improving access to treatment for hypertension through the public or private sector should be a high priority for India.

Indexed as

Antihypertensive AgentsBlood PressureHealth Knowledge, Attitudes, PracticeHypertensionAdolescentAdultAgedAwarenessCross-Sectional StudiesFemaleHumansIndiaMaleMiddle AgedPopulation SurveillancePrevalenceAntihypertensive Agents

Identifiers

PMID40121324
PMCPMC12069080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.